What is the most appropriate next step to manage insomnia in a 51‑year‑old male with chronic myeloid leukemia, low STOP‑BANG score, normal BMI, and resolved anxiety?

Limit Time in Bed to Match Actual Sleep Time (Sleep Restriction Therapy)

The most appropriate next step is to implement sleep restriction therapy by limiting his time in bed to match his actual sleep time, as this patient has developed psychophysiological insomnia with maladaptive sleep behaviors that perpetuate his insomnia despite resolution of the initial anxiety trigger. 1

Clinical Reasoning

This patient presents with classic psychophysiological insomnia that has persisted beyond the resolution of his initial precipitating factor (cancer-related anxiety). The key clinical clue is his counterproductive behavior: going to bed an hour earlier to "get more sleep" but instead spending hours tossing and turning. This has created a negative association between his bed and wakefulness, perpetuating the insomnia cycle.

Why Sleep Restriction Therapy is the Correct Choice

Sleep restriction therapy is specifically designed to:

• Consolidate sleep by enhancing homeostatic sleep drive
• Break the negative association between bed and wakefulness
• Improve sleep efficiency (ratio of sleep time to time in bed)

The technique involves 1:

1. Have the patient maintain a sleep log for 1-2 weeks to determine mean total sleep time (TST)
2. Set bedtime and wake-up times to approximate the TST (minimum 5 hours in bed)
3. Target sleep efficiency >85% (TST/time in bed × 100%)
4. Make weekly adjustments: increase time in bed by 15-20 minutes if sleep efficiency >85-90%; decrease by 15-20 minutes if <80%

This approach has guideline-level recommendation for chronic insomnia 1 and is a core component of CBT-I, which has the strongest evidence base for insomnia treatment 2, 3.

Why NOT Zolpidem

Prescribing zolpidem would be premature and potentially harmful because:

• Behavioral interventions should be first-line treatment for chronic insomnia 1
• The patient has not yet tried evidence-based behavioral approaches
• Benzodiazepine receptor agonists carry risks of dependence, tolerance, and adverse effects 1
• Medications don't address the underlying maladaptive behaviors perpetuating his insomnia
• In cancer patients specifically, CBT-I shows superior efficacy with large effect sizes (g = 0.86 post-intervention) and benefits beyond sleep, including improvements in fatigue and mood 4

Why NOT Home Sleep Apnea Test

A sleep apnea evaluation is not indicated because:

• STOP-BANG score of 2 is LOW risk for obstructive sleep apnea (scores ≥3 indicate intermediate risk, ≥5 high risk)
• BMI of 22 is normal (not overweight/obese, which is a major OSA risk factor)
• His clinical presentation is classic for psychophysiological insomnia with clear behavioral perpetuating factors
• The 15-pound weight loss since diagnosis further reduces OSA likelihood
• His insomnia has a clear temporal relationship to anxiety and maladaptive coping behaviors

Implementation Strategy

Immediate steps:

1. Instruct the patient to keep a detailed sleep diary for 1-2 weeks documenting:

   • Time to bed
   • Time out of bed
   • Estimated time to fall asleep
   • Number and duration of awakenings
   • Final wake time

2. Calculate baseline sleep efficiency and implement sleep restriction based on actual sleep time

3. Combine with stimulus control instructions 1:

   • Go to bed only when sleepy
   • Get out of bed if unable to sleep within 20 minutes
   • Use bed only for sleep and sex
   • Maintain consistent wake time daily
   • Avoid daytime napping

Common Pitfalls to Avoid

• Don't allow the patient to continue spending excessive time in bed hoping to "catch up" on sleep—this worsens sleep efficiency
• Don't restrict time in bed below 5 hours—this is the safety threshold 1
• Warn the patient about temporary increased daytime sleepiness during the first 1-2 weeks of sleep restriction
• Ensure consistent wake times even on weekends—this is critical for success
• Don't prescribe hypnotics as first-line therapy when behavioral factors are clearly perpetuating the insomnia

Evidence Strength

The recommendation for behavioral interventions, particularly sleep restriction as part of CBT-I or as a standalone therapy, has Standard/Guideline-level evidence from the American Academy of Sleep Medicine 1. The 2021 systematic review and meta-analysis confirms CBT-I as the most efficacious intervention for chronic insomnia 2, 3, with particularly strong evidence in cancer populations 4.

If behavioral interventions fail after 4-8 weeks of appropriate implementation, then pharmacologic options could be reconsidered, but this should not be the initial approach given the clear behavioral perpetuating factors in this case.